UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Management of an Elevated PSA and Biopsy Strategies in the Large Prostate

Neves, JB; Emberton, M; Kasivisvanathan, V; (2017) Management of an Elevated PSA and Biopsy Strategies in the Large Prostate. In: Kasivisvanathan, V and Challacombe, B, (eds.) The Big Prostate. (pp. 41-51). Springer: Cham, Switzerland. Green open access

[thumbnail of Neves_Big prostate chp 4 v6.pdf]
Preview
Text
Neves_Big prostate chp 4 v6.pdf - Accepted version

Download (82kB) | Preview

Abstract

An abnormally high serum PSA is still the most frequent trigger for men to enter a suspected prostate cancer diagnostic pathway. Large prostates, especially the ones with a volume over 100cc, are commonly associated with elevated PSA levels. In men with benign prostatic hyperplasia (BPH), PSA tends to increase over time, something that also occurs in men with untreated progressive prostate cancer. These two factors lead to frequent and unnecessary referrals of men with large prostates to suspected prostate cancer pathways. Many PSA derivatives and risk stratification tools have been developed in an attempt to overcome the limitations of total serum PSA and more accurately predict which men should have prostate biopsies, but translation into routine clinical practice has been hindered. Biopsy strategies may need to be adapted in the setting of a 100cc prostate. Higher sampling density schemes have been advocated for these men to ensure the diagnosis of clinically significant cancer but this can be accompanied by increased side effects. mpMRI is increasingly done prior to biopsy and can aid in the selection of men who can safely avoid biopsies. Likewise, they can help target biopsies to suspicious areas, which may represent a method of balancing adequate sampling of large prostates with adverse events.

Type: Book chapter
Title: Management of an Elevated PSA and Biopsy Strategies in the Large Prostate
ISBN-13: 9783319647036
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/978-3-319-64704-3_4
Publisher version: https://doi.org/10.1007/978-3-319-64704-3_4
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Diagnosis, Prostate, Prostatic hyperplasia, Prostatic neoplasms, Prostate-specific antigen, Biopsy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Surgical Biotechnology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: https://discovery.ucl.ac.uk/id/eprint/10041252
Downloads since deposit
62Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item